Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

BACKGROUND: A considerable number of patients with metastatic colorectal cancer progress after exhausting all approved standard therapies but maintain an adequate performance status and could be candidates for further treatment. We aim at reviewing our experience with sorafenib treatment of a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Raphael Brandão, Peixoto, Renata D'Alpino, de Sousa Cruz, Marcelo Rocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: February, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361904/
https://www.ncbi.nlm.nih.gov/pubmed/25848357
http://dx.doi.org/10.1159/000375483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361904/
https://www.ncbi.nlm.nih.gov/pubmed/25848357
http://dx.doi.org/10.1159/000375483

Ejemplares similares